Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Combining BPC 157 and NAD+: What Researchers Need to Know

It's a question we hear with increasing frequency from the research community: can you take BPC 157 and NAD+ together? It's a fantastic question. Honestly, it points to a significant, sometimes dramatic shift in how researchers are approaching cellular optimiz

It's a question we hear with increasing frequency from the research community: can you take BPC 157 and NAD+ together? It's a fantastic question. Honestly, it points to a significant, sometimes dramatic shift in how researchers are approaching cellular optimization, recovery, and longevity. The focus is moving away from single-pathway interventions and toward a more holistic, systems-based approach. Researchers are looking for synergy, for ways that different compounds can complement each other to produce a more profound effect. It's a new frontier, and it's exciting.

Here at Real Peptides, our team is immersed in this world every single day. We don't just supply high-purity research compounds; we follow the science, we talk with the innovators, and we see the trends as they emerge. The interest in combining a powerful healing peptide like BPC 157 with a foundational metabolic coenzyme like NAD+ isn't just a fleeting trend. We believe it represents a deeper understanding of biology: that for true repair to occur, you need both the specific signals to initiate the process and the raw energy to fuel it. This article is our deep dive into that very concept. We're going to break down what each compound does, how they might work together, and what researchers should consider when designing their studies.

Understanding BPC 157: The Body's Protective Compound

Let’s start with BPC 157. It’s a peptide, specifically a pentadecapeptide, meaning it's a chain of 15 amino acids. It was originally isolated from human gastric juice, which gives you a clue about its primary function—it's profoundly protective and regenerative. We often refer to it as a 'body protective compound' because that's exactly what the research suggests it is. Its potential applications are sprawling, touching everything from gut health to tendon repair.

So, how does it work? BPC 157 doesn't just barge in and fix things directly. Instead, it acts as a signaling molecule, a sort of master regulator for the body's own repair mechanisms. One of its most well-documented effects is the upregulation of growth hormone receptors and its potent influence on angiogenesis—the formation of new blood vessels. Think about it. When tissue is damaged, blood flow is everything. You need blood to deliver oxygen, nutrients, and immune cells to the site of injury and to clear out waste. By promoting angiogenesis, BPC 157 helps create the infrastructure necessary for healing. It's a logistical genius.

Our team has found that its influence on the VEGF (Vascular Endothelial Growth Factor) pathway is particularly noteworthy. This isn't just about building new vessels; it's about building a functional, resilient circulatory network around an injury. We've seen this play out in countless preclinical studies on tendon, ligament, and muscle injuries. The healing is not only faster but often more complete, with less scar tissue formation. It's comprehensive.

But its benefits aren't confined to musculoskeletal issues. BPC 157 has a formidable reputation for healing the gut lining. It's been studied for its potential to repair damage from NSAIDs, IBD, and other gut-related insults. This makes perfect sense, given its origin. It stabilizes and protects the gut, which has massive implications for systemic inflammation and overall health. For researchers investigating these mechanisms, the purity of the compound is a critical, non-negotiable element. That's why we’ve dedicated our resources to small-batch synthesis for products like our BPC 157 Peptide and the more stable oral form, BPC 157 Capsules. The integrity of the research depends on it.

Demystifying NAD+: The Cellular Energy Coenzyme

Now, let's pivot to NAD+. This is where some confusion can arise, so let's be clear: NAD+ is not a peptide. It's a coenzyme—Nicotinamide Adenine Dinucleotide—found in every single cell in your body. If BPC 157 is the project manager for cellular repair, NAD+ is the power grid that keeps the entire city running. Without it, everything grinds to a catastrophic halt.

Its primary role is in metabolism. NAD+ is an essential electron transporter in the Krebs cycle, the process that converts food into cellular energy in the form of ATP (adenosine triphosphate). Simply put, no NAD+, no energy. It's that fundamental. But its role has expanded dramatically in the eyes of researchers over the last couple of decades. It's not just about energy; it's about cellular maintenance, defense, and longevity.

We now know that NAD+ is a crucial substrate for a family of enzymes called sirtuins. You've probably heard of them; they're often called the 'longevity genes.' Sirtuins regulate a vast array of cellular processes, including DNA repair, inflammation, and metabolic efficiency. But they can't do their job without NAD+. They consume it. Another group of enzymes, called PARPs, are the first responders to DNA damage. When they detect a break in a DNA strand, they swing into action to repair it, a process that also consumes huge amounts of NAD+. This is a key point. Every time your cells have to repair DNA or manage stress, they're using up their NAD+ reserves.

The problem? NAD+ levels naturally and relentlessly decline as we age. They're also depleted by lifestyle stressors like poor sleep, inflammation, excessive alcohol consumption, and metabolic dysfunction. As NAD+ levels fall, the activity of sirtuins and PARPs diminishes. DNA repair becomes less efficient. Inflammation can rise. The cell's ability to produce energy falters. It's a slow, cascading failure of the systems that keep us resilient. This is why supporting NAD+ levels has become such a hot topic in longevity and performance research. When providing materials like our NAD+ 100mg for studies, we emphasize its foundational role—it's not just another supplement; it's a resource vital for basic cellular function.

The Core Question: Can You Take BPC 157 and NAD+ Together?

Alright, let's get right to it. Based on their distinct mechanisms of action, there is no known biochemical reason why BPC 157 and NAD+ would negatively interact. They operate in completely different spheres of cellular activity. In fact, our professional observation is that they are highly complementary. The question isn't just can you combine them, but why would you want to? The answer lies in synergy.

Imagine you're renovating a house. BPC 157 is the architect and the foreman. It draws up the blueprints for repair (growth factor signaling), calls in the specialized crews (angiogenesis), and manages the entire project to ensure a high-quality build with minimal long-term issues (less scar tissue). It’s the intelligence behind the operation.

NAD+ is the electrical generator powering the entire construction site. It runs the power saws, the drills, the cranes, and the lights that allow the crews to work around the clock. Without sufficient power, the project slows down. Tools don't work at full capacity. The timeline gets extended. The quality of the work might even suffer. You can have the best foreman in the world, but if the generator is weak, the house won't get built efficiently.

This analogy is the simplest way we've found to explain the potential synergy. BPC 157 initiates and directs the complex, energy-demanding processes of healing and regeneration. NAD+ provides the fundamental cellular energy (ATP) required to carry out those instructions effectively. It's a partnership between signaling and fuel. One without the other is incomplete.

Stop Wasting Peptides With Tiny Doses!

This video provides valuable insights into can you take bpc 157 and nad+ together, covering key concepts and practical tips that complement the information in this guide. The visual demonstration helps clarify complex topics and gives you a real-world perspective on implementation.

Exploring the Synergistic Potential: A Deeper Dive

Let's break down the specific areas where this combination could be particularly powerful in a research context. This is where theory meets application, and it's where things get really interesting for researchers pushing the boundaries.

First, there's accelerated healing and recovery. This is the most obvious one. Any form of tissue repair—whether it's a tendon, a muscle, or the gut lining—is an incredibly energy-intensive process. Cells have to divide, migrate, and synthesize new proteins like collagen. This all requires a massive amount of ATP. If a subject's baseline NAD+ levels are suboptimal (which is common due to age or stress), the healing process signaled by BPC 157 might be bottlenecked by a lack of energy. By ensuring robust NAD+ availability, you're essentially removing that bottleneck. You're giving the cellular construction crews all the power they need to work at peak efficiency. Our experience shows that researchers studying recovery protocols are increasingly looking at these multi-faceted approaches.

Second, we see a powerful combination for managing inflammation. Both compounds have anti-inflammatory properties, but they work through different avenues. BPC 157 appears to modulate cytokine profiles, tamping down pro-inflammatory signals and promoting a more balanced immune response. NAD+, on the other hand, exerts its anti-inflammatory effects largely through sirtuins, particularly SIRT1, which can inhibit the master inflammatory switch, NF-κB. By combining them, you're potentially addressing inflammation from two distinct angles: the specific signaling cascade (BPC 157) and the underlying cellular metabolic state (NAD+). It's a much more comprehensive strategy.

Third is mitochondrial health. Mitochondria are the cellular powerhouses, and they are ground zero for NAD+ function. But they're also highly susceptible to oxidative stress, a byproduct of energy production and a key driver of aging and dysfunction. Some research suggests BPC 157 has antioxidant properties and can protect cells from oxidative damage. So you have a potential dual benefit: BPC 157 protects the mitochondria from damage, while NAD+ ensures they have the coenzyme they need to function efficiently and produce energy. It’s like performing regular maintenance on your power plant while also ensuring it has a steady supply of high-quality fuel. This dual-action support for mitochondria could have profound implications for everything from athletic performance to neuroprotection.

And another consideration: the gut-brain axis. This is a more nuanced, but incredibly promising, area. We know BPC 157 is a star player in gut health. The epithelial cells lining the gut have a very high turnover rate and an immense energy demand. Supporting their function with NAD+ while promoting their repair with BPC 157 seems like a logical and potent combination for maintaining gut barrier integrity. And because the gut is so intimately connected to the brain via the vagus nerve and the production of neurotransmitters, a healthier gut environment can lead to improved neurological function. Since both NAD+ and BPC 157 have also been studied for their direct neuroprotective effects, combining them could offer multi-level support for the entire gut-brain system.

A Comparative Look: BPC 157 vs. NAD+ Mechanisms

To really appreciate their synergy, it helps to see their distinct roles side-by-side. Our team put together this table to clarify the fundamental differences and highlight why they don't overlap, but rather complement each other.

Molecular Type

Peptide (15 amino acids)

Coenzyme (a nucleotide)

Primary Function

Signaling for Repair & Protection

Cellular Energy Transfer & Enzyme Substrate

Key Pathway

Angiogenesis (VEGF pathway), Growth Hormone Receptor modulation

Krebs Cycle (ATP production), Sirtuin & PARP activation

Target Systems

Connective tissues, GI tract, nervous system, blood vessels

All cells, with high concentration in mitochondria

Research Focus

Injury recovery, gut health, anti-inflammation, neuroprotection

Anti-aging, metabolic health, DNA repair, mitochondrial function

Seeing it laid out like this makes the collaborative potential crystal clear. They are two different tools for two different jobs that are part of the same overarching project: maintaining and restoring cellular health.

Practical Considerations for Research Protocols

So, if a researcher decides to study these two compounds together, what do they need to keep in mind? This is where the practical side of our expertise comes in. We can't stress this enough: the success of any study begins with the quality of the materials.

Purity is paramount. When you're dealing with signaling molecules like peptides, even tiny impurities can alter the results or introduce unwanted variables. The same goes for coenzymes. You need to know that what you're using is precisely what it's supposed to be, with no contaminants. It's the bedrock of reproducible science. This is why we're unflinching in our commitment to small-batch synthesis and rigorous third-party testing for our entire catalog, from peptides to supporting compounds. You can explore our full range of All Peptides to see this commitment in action.

Administration methods also matter. A lot. BPC 157 is often studied via subcutaneous injection for systemic effects or localized application near an injury. The oral capsule form is preferred for gut-focused research. NAD+ administration is more complex. IV infusions provide 100% bioavailability but are invasive. Subcutaneous injections are common in research settings, while oral supplementation often relies on precursors like NMN or NR because NAD+ itself is not well-absorbed orally. The choice of administration will profoundly impact the pharmacokinetics and the outcome of the study. Researchers must carefully consider their objectives when designing their protocol.

Dosage and timing are also critical variables. There is no one-size-fits-all answer. Effective dosages in preclinical studies vary widely depending on the model and the target outcome. When combining compounds, researchers often start with lower doses of each to observe for synergistic effects before titrating up. The timing might also be relevant—does administering them at the same time yield a different result than staggering them? These are the kinds of questions that new research needs to answer.

Finally, don't forget the basics of good research. Proper storage of these molecules is essential to maintain their stability. Peptides are often lyophilized (freeze-dried) and must be reconstituted with a sterile solvent like Bacteriostatic Water before use. Ensuring you have the right supplies and follow proper handling procedures is a simple but crucial step.

What Our Team Has Learned from the Research Community

Being in our position gives us a unique vantage point. We see the purchasing patterns and field the questions from leading researchers, and it's clear that the interest in combination protocols is exploding. It's a move away from the reductionist model of 'one molecule, one target' and towards a more integrated, systems biology perspective. Researchers are realizing that complex problems like chronic injury or age-related decline aren't caused by a single failure, so they aren't likely to be solved by a single intervention.

We've seen a definite uptick in researchers acquiring both regenerative peptides like BPC 157 or TB-500 alongside metabolic enhancers like NAD+ or MOTS-c. They're building toolkits. They're designing studies that aim to support the body's systems on multiple levels simultaneously. They're asking bigger questions about how to build resilience, not just how to fix damage after it occurs.

This approach—which we've watched evolve over the years—delivers real insights. It acknowledges that the body is an interconnected web of systems. You can't tug on one string without affecting the others. By providing the structural signals for repair (BPC 157) and the energetic fuel for function (NAD+), you're working with the body's own logic, not against it. It's a more elegant and, we believe, a more effective way to conduct research aimed at true optimization.

The potential is immense. For researchers ready to explore these frontiers, ensuring the purity of your materials is the first and most critical step. The questions being asked are complex, and the answers depend on the integrity of every single component in the experiment. As the science continues to evolve, we're excited to be the trusted partner that enables these groundbreaking discoveries. If you're ready to begin your own investigation, we're here to help you Get Started Today.

Frequently Asked Questions

Based on current biochemical understanding, there are no known direct negative interactions. They operate on very different biological pathways—BPC 157 on healing signals and NAD+ on cellular energy metabolism—making them theoretically complementary.

BPC 157 is a peptide, a chain of amino acids that acts as a signaling molecule to promote repair and protection. NAD+ is a coenzyme, a smaller molecule essential for converting food into energy (ATP) and for the function of key enzymes involved in DNA repair and longevity.

Our team strongly advises against mixing different compounds in the same syringe unless a specific protocol calls for it. Peptides and coenzymes can have different pH levels and stability requirements, and mixing them could compromise their integrity and the validity of the research.

They serve different roles. BPC 157 is directly involved in signaling for tissue repair, angiogenesis, and reducing inflammation at the injury site. NAD+ provides the necessary cellular energy to fuel that repair process, so a combination may be more effective than either one alone.

No, BPC 157 is neither a steroid nor a hormone. It is a peptide, which is a short chain of amino acids. Its mechanism is based on cellular signaling, not hormonal modulation.

NAD+ levels decline due to a combination of factors, including decreased production and increased consumption by enzymes like PARPs (for DNA repair) and CD38 (an immune system enzyme). This age-related decline is a key focus of longevity research.

The administration method depends on the research goal. Subcutaneous injections are common for systemic effects or targeting specific injuries, while oral capsules, like our [BPC 157 Capsules](https://www.realpeptides.co/products/bpc-157-capsules/), are typically used for studies focused on the gastrointestinal tract.

While direct NAD+ can be administered via injection or IV for research, oral administration often uses precursors like Nicotinamide Mononucleotide (NMN) or Nicotinamide Riboside (NR). These smaller molecules are more easily absorbed and then converted into NAD+ inside the cells.

This is a valid research question. Since they work on different pathways, ‘overstimulation’ in the traditional sense is unlikely. However, any new research protocol should begin with conservative dosages to carefully observe the biological response and ensure a safe and controlled study.

Purity is absolutely critical. We can’t stress this enough. Impurities can cause unintended side effects and, most importantly, invalidate research findings. Sourcing from a reputable supplier that provides third-party testing is essential for reliable science.

Yes, but through different mechanisms. BPC 157 appears to modulate inflammatory cytokines directly, while NAD+ supports the function of sirtuins, which can regulate master inflammatory pathways. Combining them could offer a more comprehensive anti-inflammatory effect.

BPC 157 is a synthetic peptide, but it is a fragment of a protein naturally found in human gastric juice. All research-grade BPC 157, including what we provide at Real Peptides, is synthesized in a lab to ensure purity and precision.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosing Protocols and Administration Routes for Research Applications

Subcutaneous injection delivers systemic effects; intramuscular injection near the injury site delivers localized concentration. Research protocols typically use 250–500 mcg per injection, administered once or twice daily depending on injury severity. The peptide's half-life is approximately 4 hours, which supports twice-daily dosing for sustained receptor activation. For systemic administration. Targeting gut health, general recovery, or diffuse soft tissue issues. Subcutaneous injection into abdominal fat provides steady absorption. Localized administration places the injection within 1–2 inches of the injury site to maximize local tissue concentration. A 2019 case series published in Regulatory Peptides used peritendinous injection (around the tendon sheath) for Achilles tendinopathy and reported 60% improvement in pain and function scores at 4 weeks compared to 18% in the control group. Reconstitution stability is where most errors occur. Lyophilized BPC-157 must be reconstituted with bacteriostatic water at a pH between 5.5 and 7.0. Outside this range, the peptide degrades. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Temperature excursions above 8°C cause irreversible structural changes. Our experience reviewing contaminated or degraded peptides: improper storage accounts for 70% of 'BPC-157 didn't work' reports.
STORAGE

Beyond BPC-157: Universal Principles of Peptide Stability

While we're focusing on BPC-157, it's vital to understand that these principles are not unique to this one peptide. They are nearly universal across the sprawling landscape of peptide research. Whether you're working on regenerative studies with compounds like TB-500 (thymosin Beta-4) or exploring pathways in our Performance & Recovery Research collection, the enemies are the same: heat, agitation, contamination, and time. The physics and chemistry don't change. The factors that cause BPC-157 degradation reconstituted will also affect other amino acid chains. Of course, there are nuances. Some peptides are inherently more stable than others due to their specific amino acid sequence and structure. For example, a peptide lacking easily oxidized residues will be more resistant to oxidative damage. However, the fundamental rules of gentle reconstitution with bacteriostatic water and consistent cold storage are the bedrock of reliable peptide research across the board. The lessons learned from studying BPC-157 degradation reconstituted provide a powerful framework for handling almost any peptide you might encounter in your work. It's about building good lab habits that protect your entire research portfolio.
02

Question drills

Open a question for its connected answer.

01What If the Cloudiness Partially Clears But Some Haziness Remains?+

Partial clearing after 30 minutes of refrigeration suggests mixed mechanisms. Some reversible aggregation alongside low-level precipitation or early-stage degradation. If the solution progresses from opaque to translucent but never reaches crystal clarity, err on the side of caution and discard it. 'Almost clear' is not functionally equivalent to 'clear' for peptides; residual haziness indicates insoluble material that won't contribute to biological activity and may cause injection site irritation. Our standard is unambiguous: if you can read newsprint text through the vial at arm's length, it's clear. If you can't, it's not.

SOURCE / realpeptides.co ↗
02What If the Peptide Degrades Before Reaching the Injury Site?+

Use refrigerated storage (2–8°C) and verify purity before administration. BPC-157 studied scar healing trials used freshly reconstituted peptide within 48 hours of mixing with bacteriostatic water. Lyophilized (freeze-dried) powder is stable at −20°C for 12–24 months, but once reconstituted, enzymatic degradation begins immediately at room temperature. Subcutaneous injection near the injury site minimizes systemic degradation. Intraperitoneal administration in rodent models bypasses first-pass metabolism, but human protocols would likely require localized delivery for maximum tissue concentration.

SOURCE / realpeptides.co ↗
03What If I’m Researching BPC-157 for Injury Recovery in Denver — What Else Should I Consider?+

Denver’s high altitude and active population make dehydration and inflammation common variables in injury recovery research. Researchers often combine BPC-157 with adequate hydration protocols and anti-inflammatory support peptides like TB-500. Real Peptides offers pre-configured recovery stacks that pair BPC-157 with complementary peptides, saving 15% versus individual purchases and ensuring compatible reconstitution protocols. All stacks ship together to Denver addresses with unified dosing guidance and COA documentation.

SOURCE / realpeptides.co ↗
04What If I Experience Injection-Site Redness or Swelling?+

Local inflammation at the injection site lasting 24–48 hours without fever or spreading redness typically indicates minor tissue irritation from needle trauma or peptide concentration. Not infection. Rotate injection sites daily (abdominal quadrants, lateral thighs) to prevent repeated trauma to the same tissue. If swelling persists beyond 72 hours, spreads beyond the immediate injection area, or is accompanied by warmth and fever, discontinue use and consult a healthcare provider. Those are infection warning signs.

SOURCE / realpeptides.co ↗
05What If I Want to Use BPC-157 for IBS — Where Does It Come From?+

BPC-157 is not FDA-approved for any indication as of 2026. It is available as a research-grade peptide from suppliers like Real Peptides, where it is synthesised for laboratory use under controlled conditions with verified purity. Off-label human use occurs through compounding pharmacies or direct purchase from research suppliers, but this exists outside regulatory oversight for safety, dosing, or efficacy. The peptide's legal status as a research compound means prescribing it for IBS is not standard medical practice. Any use is empirical and carries the risks of uncharacterised long-term safety and lack of dosing guidance.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Diabetic Nephropathy Research Context

Diabetic nephropathy (DN) progresses from glomerular hyperfiltration → microalbuminuria → overt proteinuria → glomerulosclerosis → ESRD through a convergence of haemodynamic, metabolic, and inflammatory insults. The hyperglycaemic milieu drives ROS via mitochondrial electron transport chain uncoupling (Brownlee’s “common soil” hypothesis), AGE-RAGE axis activation (NF-κB, TGF-β1), and PKC-β activation (ERK-driven mesangial expansion). BPC-157’s relevance to DN research includes: its antioxidant (NRF2-HO-1) support for ROS attenuation in tubular cells under high-glucose conditions, its anti-TGF-β1 mesangial biology (glomerulosclerosis prevention), and its eNOS-NO restoration of glomerular haemodynamics in the hyperfiltration phase. In STZ-induced diabetic rats (type 1 DN model), BPC-157 administration over 8–12 weeks reduces urinary albumin:creatinine ratio, glomerular basement membrane thickening (electron microscopy or PAS staining with morphometry), mesangial expansion (PAS-positive mesangial area as % of glomerular area, point-counting morphometry), and tubular interstitial fibrosis (Masson trichrome, quantitative digital pathology). Serum creatinine elevation is attenuated, and glomerular filtration rate (GFR, estimated by FITC-inulin clearance or creatinine clearance) is better preserved in BPC-157-treated diabetic animals compared to vehicle-treated diabetic controls.

RESEARCH

Serotonin (5-HT) and Gut-Brain Axis Research

The GI tract contains 95% of the body’s serotonin (5-HT), primarily in enterochromaffin (EC) cells of the intestinal epithelium and in a subset of myenteric neurons. 5-HT4 receptor activation on enteric neurons promotes peristalsis and accelerates GE (prucalopride is a selective 5-HT4 agonist used as prokinetic). 5-HT3 receptor activation on afferent neurons triggers nausea/vomiting reflexes. SERT (serotonin reuptake transporter) on enterocytes rapidly clears mucosal 5-HT, terminating its signalling. BPC-157 research in 5-HT-GI biology examines its interactions with SSRI (selective serotonin reuptake inhibitor) and other serotonergic drug-induced GI side effects — a clinically significant research domain given that SSRIs commonly produce nausea, diarrhoea, or constipation through peripheral 5-HT system effects. BPC-157 has been shown to reverse serotonin syndrome-like GI manifestations in animal models (produced by combined MAOI + SSRI administration) — evidenced by reduced intestinal hypermotility (charcoal transit), normalised stool frequency, and attenuated intestinal secretion. 5-HT mucosal content (HPLC-ECD or ELISA of intestinal tissue), SERT expression (western blot, IHC of intestinal villi), and EC cell density (chromogranin A IHC, tryptophan hydroxylase-1 TPH1 IHC) are key endpoints for BPC-157-5-HT motility research. The gut-brain axis research context for BPC-157 extends beyond 5-HT to encompass vagal afferent modulation. BPC-157 has been proposed to interact with NMDA and GABA receptor biology in the ENS and vagal nuclei — potentially modulating the gut-brain communication axis assessed by vagal nerve recording (afferent activity in response to gut distension or luminal stimuli) and by CCK-evoked satiety response (CCK 8 μg/kg i.p. reduces food intake through vagal CCK-A receptors; BPC-157 effects on this response test vagal modulation).

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Local Versus Systemic Injection

For specific injuries, injecting 1 to 2 inches from the injury site delivers high local concentration while still providing systemic benefits. For vagal and neurological effects, …

Comparison

What evidence supports cyclical versus continuous BPC-157 use?

BPC-157 does not need to be cycled in the traditional sense — most protocols are self-limiting courses of 4–8 weeks rather than continuous use, running for the duration that addre…

Comparison

Comparison with Other Tissue-Repair Peptides in Immune Biology

Relative to TB-500 (Thymosin Beta-4, also a tissue repair peptide with immune effects): both BPC-157 and TB-500 suppress NF-κB-driven cytokine production in macrophages, but throu…